Cargando…
Targeting a Multidrug-Resistant Pathogen: First Generation Antagonists of Burkholderia cenocepacia’s BC2L-C Lectin
[Image: see text] Multidrug-resistant pathogens such as Burkholderia cenocepacia have become a hazard in the context of healthcare-associated infections, especially for patients admitted with cystic fibrosis or immuno-compromising conditions. Like other opportunistic Gram-negative bacteria, this pat...
Autores principales: | Bermeo, Rafael, Lal, Kanhaya, Ruggeri, Davide, Lanaro, Daniele, Mazzotta, Sarah, Vasile, Francesca, Imberty, Anne, Belvisi, Laura, Varrot, Annabelle, Bernardi, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594048/ https://www.ncbi.nlm.nih.gov/pubmed/36174276 http://dx.doi.org/10.1021/acschembio.2c00532 |
Ejemplares similares
-
Prediction and Validation of a Druggable Site on Virulence Factor of Drug Resistant Burkholderia cenocepacia
por: Lal, Kanhaya, et al.
Publicado: (2021) -
Glycomimetic antagonists of BC2L-C lectin: insights from molecular dynamics simulations
por: Antonini, Giulia, et al.
Publicado: (2023) -
Identification of New L-Fucosyl and L-Galactosyl Amides as Glycomimetic Ligands of TNF Lectin Domain of BC2L-C from Burkholderia cenocepacia
por: Mazzotta, Sarah, et al.
Publicado: (2023) -
BC2L-C N-Terminal Lectin Domain Complexed with Histo Blood Group Oligosaccharides Provides New Structural Information
por: Bermeo, Rafael, et al.
Publicado: (2020) -
Burkholderia cenocepacia BC2L-C Is a Super Lectin with Dual Specificity and Proinflammatory Activity
por: Šulák, Ondřej, et al.
Publicado: (2011)